Supreme Court to Hear Case Challenging FDA's Ban of Flavored Vapes

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on July 2, 2024.

By Robin Foster HealthDay Reporter

TUESDAY, July 2, 2024 -- In a case that will test the U.S. Food and Drug Administration's authority to approve or reject new vaping products, the U.S. Supreme Court said Tuesday it will weigh whether the agency was legally allowed to ban flavored e-cigarettes.

In recent years, the FDA has declined to approve flavored vapes, saying they pose a health risk because they encourage young people to use e-cigarettes. But they remain widely available on the U.S. market.

Meanwhile, vaping companies claim the agency got it wrong, arguing that their products can be used to help people stop smoking traditional cigarettes.

E-cigarette makers have filed lawsuits around the country challenging the FDA's decisions, NBC News reported.

While the FDA has won most of those cases, it appealed to the Supreme Court after the 5th U.S. Circuit Court of Appeals issued a January ruling in favor of two vape companies seeking to have their products approved.

That appeals court concluded that the FDA failed to correctly assess the companies' requests in violation of a federal law called the Administrative Procedure Act, NBC News reported.

"The Supreme Court should overturn the Fifth Circuit decision because it is misguided and, if left to stand, would cause significant harm to public health and especially to the health of our kids," Yolonda Richardson, president and CEO of Campaign for Tobacco-Free Kids, said in a statement. "This decision is also in direct conflict with the decisions of seven other federal courts of appeals that have upheld FDA marketing denial orders for flavored e-cigarettes."

The case the Supreme Court has agreed to hear was brought by Triton Distribution, which makes e-liquids for vape pens in such flavors as "Signature Series Mom's Pistachio" and "Suicide Bunny Mother's Milk and Cookies," and Vapestasia, which has sought approval for flavors including "Iced Pineapple Express" and "Killer Kustard Bluebery," NBC News reported.

Even as legal cases swirl around flavored vaping products, there has been a growth in teens using other nicotine-containing products.

"Youth e-cigarette use remains a serious public health problem in the United States," Richardson said. "According to the 2023 National Youth Tobacco Survey, 2.1 million kids use e-cigarettes and nearly 90% of them use flavored products, with the most-reported flavors including fruit, candy/desserts/other sweets, mint and menthol."

Despite that fact, the FDA recently approved menthol-flavored e-cigarettes for the first time and also rescinded its ban on Juul selling its vape products.

"The FDA’s decision today to authorize the sale of four menthol-flavored e-cigarettes made by NJOY -- the first time the agency has authorized the sale of any flavored e-cigarettes -- is deeply troubling given the extensive scientific evidence that menthol is a flavor that appeals to kids and the FDA’s repeated conclusions that flavored e-cigarettes, including menthol-flavored products, have driven youth e-cigarette use," Richardson said in a statement when the agency approved menthol vaping products.

Sources

  • Campaign for Tobacco-Free Kids, statement, July 2, 2024
  • NBC News

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2024-07-03 01:15

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords